- $242.21m
- $231.84m
- $28.75m
- 85
- 51
- 49
- 65
Annual income statement for Pure Cycle, fiscal year end - August 31st, USD millions except per share, conversion factor applied.
2020 August 31st | 2021 August 31st | 2022 August 31st | 2023 August 31st | 2024 August 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 25.9 | 17.1 | 23 | 14.6 | 28.7 |
| Cost of Revenue | |||||
| Gross Profit | 7.54 | 10.7 | 16.4 | 8.04 | 19.8 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 24.3 | 11.9 | 12.9 | 12.5 | 16.5 |
| Operating Profit | 1.51 | 5.27 | 10.1 | 2.07 | 12.2 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 8.92 | 26.6 | 12.7 | 6.22 | 15.6 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 6.75 | 20.1 | 9.62 | 4.7 | 11.6 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 6.75 | 20.1 | 9.62 | 4.7 | 11.6 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 6.75 | 20.1 | 9.62 | 4.7 | 11.6 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.325 | 0.834 | 0.398 | 0.195 | 0.481 |